Merck & Co.'s [11C]L-235 can be used to assess target engagement of cathepsin K inhibitors June 1, 2021
Bacteriophage delivery of TNF-alpha gene therapy suppresses chondrosarcoma tumors in vivo June 1, 2021
Extracellular nicotinamide phosphoribosyltransferase suggested as a viable ARDS therapeutic target May 31, 2021
Disulfiram/copper gluconate studied in phase I for treatment-refractory multiple myeloma May 31, 2021
Phase I trial explores use of BIVV-001 in adults with type 2N and 3 von Willebrand disease May 31, 2021
RSS